dansylarginine n-(3-ethyl-1,5-pentanediyl)amide has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrogio, C; Gasic, G; Karpatkin, S; Pearlstein, E | 2 |
2 other study(ies) available for dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and Adenocarcinoma
| Article | Year |
|---|---|
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide.
Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Cell Transformation, Viral; Colonic Neoplasms; Complement Inactivator Proteins; Dansyl Compounds; Humans; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Platelet Aggregation; Rabbits; Simian virus 40 | 1982 |
Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.
Topics: Adenocarcinoma; Animals; Arginine; Cell Line; Colonic Neoplasms; Dansyl Compounds; Humans; Mice; Neoplasms, Experimental; Neoplastic Cells, Circulating; Neuraminidase; Phospholipases A; Phospholipases A2; Platelet Aggregation; Rabbits; Thrombin; Trypsin | 1981 |